glp-1 employer healthcare costs Perspectives from employers on the and issues associated with covering agonists for weight loss GLP-1 drugs could lead to

Our experienced medical team at Thrive Med Spa is here to guide you through every step of your weight loss transformation

"I feel like, like a whole new life was started for me," Steensma said

References Jalleh RJ, Plummer MP, Marathe CS, et al

Glucose-dependent insulinotropic polypeptide receptor therapies for the treatment of obesity, do agonists = antagonists

GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), as well as the dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro, Zepbound), may contribute to this uncomfortable symptom through their effects on digestion

Previous meta-analyses have indicated that tirzepatide might potentially decrease the risk of cardiovascular events by affecting cardiac cells, the pancreas, and other tissues directly and indirectly [2]